Skip to main content
Premium Trial:

Request an Annual Quote

Kathleen Wiltsey, Neil Cook

Premium
Sequenom has elected Kathleen Wiltsey to its board of directors. Wiltsey joined Amgen in 1984 as business development manager and served in a variety of roles at the company, including vice president, before retiring in 1998. She is also executive director for the development and launch of the Archon X Prize for Genomics, a board member of Lexicon Pharmaceuticals, and president elect of the board of the associates of the California Institute of Technology.
 

 
Agilent Technologies has appointed Neil Cook as vice president and director of the Molecular Technology Laboratory at Agilent Laboratories. Cook also will serve as the research and development/technology manager for Agilent's Life Sciences and Chemical Analysis business. In this role, he will be responsible for guiding the future technology direction and R&D strategy for LSCA across its life sciences, materials science, and chemical analysis businesses.
 
Prior to joining Agilent, Cook was vice president for research and business development and chief scientific officer of PerkinElmer’s Life and Analytical Sciences division. Previously, Cook held vice president positions at Amersham Biosciences (now part of GE Healthcare) in corporate development, drug discovery marketing, and R&D.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.